Flexion's pain drug succeeds in late-stage study

(Reuters) - Flexion Therapeutics Inc on Tuesday said its lead drug met the main goal of reducing pain in patients with moderate to severe osteoarthritis knee pain in a late-stage study.

http://ift.tt/xePdMM

from Reuters: Health News
via animenewspro